Overview

Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of the ophthalmic solution PRO-155 in patients post phacoemulsification.
Phase:
Phase 2
Details
Lead Sponsor:
Laboratorios Sophia S.A de C.V.
Treatments:
Nepafenac
Ophthalmic Solutions